Stay updated with breaking news from Nasdaq azn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Axxcess Wealth Management LLC boosted its position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 28.7% in the 4th quarter, HoldingsChannel.com reports. The firm owned 24,046 shares of the company’s stock after buying an additional 5,362 shares during the quarter. Axxcess Wealth Management LLC’s holdings in AstraZeneca were worth $1,620,000 at the end […]
Summit Financial LLC acquired a new position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 3,078 shares of the company’s stock, valued at approximately $207,000. Several other institutional investors have also added to or […]
Cozad Asset Management Inc. grew its holdings in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 20.3% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 32,249 shares of the company’s stock after acquiring an additional 5,450 shares during the period. Cozad Asset Management Inc.’s holdings in […]
Cozad Asset Management Inc. lifted its holdings in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 20.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 32,249 shares of the company’s stock after buying an additional 5,450 shares during the period. […]
AstraZeneca PLC (NASDAQ:AZN – Free Report) – Analysts at Leerink Partnrs lifted their FY2025 earnings per share (EPS) estimates for shares of AstraZeneca in a research report issued to clients and investors on Wednesday, April 24th. Leerink Partnrs analyst A. Berens now anticipates that the company will post earnings of $5.12 per share for the […]
Headlands Technologies LLC lifted its position in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 966.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 31,002 shares of the company’s stock after purchasing an additional 28,094 shares during the quarter. AstraZeneca accounts for approximately 0.6% of […]
Bryn Mawr Capital Management LLC lifted its stake in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 0.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 61,866 shares of the company’s stock after purchasing an additional 164 shares during the period. Bryn Mawr […]
AstraZeneca (NASDAQ:AZN – Free Report) had its price objective raised by BMO Capital Markets from $80.00 to $82.00 in a report published on Friday, Benzinga reports. They currently have an outperform rating on the stock. Several other brokerages have also weighed in on AZN. Morgan Stanley initiated coverage on AstraZeneca in a report on Tuesday, […]
Harvest Fund Management Co. Ltd grew its stake in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 11.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,117 shares of the company’s stock after acquiring an additional 533 shares during the quarter. […]
Sage Mountain Advisors LLC decreased its stake in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 5.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,859 shares of the company’s stock after selling 320 shares during the quarter. Sage […]